Journal
FRONTIERS IN IMMUNOLOGY
Volume 12, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.629193
Keywords
SARS-CoV-2; cytokine response; influenza A; MERS; and SARS-CoV; literature analysis; systematic review
Categories
Funding
- UKRI Biotechnological and Biosciences Research Council (BBSRC) - Norwich Research Park Biosciences Doctoral Training Partnership [BB/M011216/1, BB/S50743X/1]
- Earlham Institute (Norwich, UK)
- Quadram Institute (Norwich, UK)
- UKRI BBSRC UK [BB/J004529/1, BB/P016774/1, BB/CSP17270/1]
- MRC [MR/N023781/1]
- Histiocytosis Society, USA
- BBSRC ISP grant [BB/R012490/1, BBS/E/F/000PR10353, BBS/E/F/000PR10355]
- BBSRC [1799901, BBS/E/T/000PR9819, BB/S50743X/1] Funding Source: UKRI
Ask authors/readers for more resources
The hyper-induction of pro-inflammatory cytokines, also known as a cytokine storm or CRS, is a key aspect of the current SARS-CoV-2 pandemic, contributing to mortality in certain COVID-19 patients. By analyzing cytokine responses to various viral infections, it was found that SARS-CoV-2 induces a unique dysregulation in the type-I interferon response compared to other respiratory viruses. This study's findings could potentially aid specialists in identifying interventions to alleviate CRS in various diseases and evaluate their applicability in COVID-19 cases.
Hyper-induction of pro-inflammatory cytokines, also known as a cytokine storm or cytokine release syndrome (CRS), is one of the key aspects of the currently ongoing SARS-CoV-2 pandemic. This process occurs when a large number of innate and adaptive immune cells activate and start producing pro-inflammatory cytokines, establishing an exacerbated feedback loop of inflammation. It is one of the factors contributing to the mortality observed with coronavirus 2019 (COVID-19) for a subgroup of patients. CRS is not unique to the SARS-CoV-2 infection; it was prevalent in most of the major human coronavirus and influenza A subtype outbreaks of the past two decades (H5N1, SARS-CoV, MERS-CoV, and H7N9). With a comprehensive literature search, we collected changing the cytokine levels from patients upon infection with the viral pathogens mentioned above. We analyzed published patient data to highlight the conserved and unique cytokine responses caused by these viruses. Our curation indicates that the cytokine response induced by SARS-CoV-2 is different compared to other CRS-causing respiratory viruses, as SARS-CoV-2 does not always induce specific cytokines like other coronaviruses or influenza do, such as IL-2, IL-10, IL-4, or IL-5. Comparing the collated cytokine responses caused by the analyzed viruses highlights a SARS-CoV-2-specific dysregulation of the type-I interferon (IFN) response and its downstream cytokine signatures. The map of responses gathered in this study could help specialists identify interventions that alleviate CRS in different diseases and evaluate whether they could be used in the COVID-19 cases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available